MedPath

Halla Medical Foundation

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:0
Completed:8

Trial Phases

2 Phases

Phase 4:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (80.0%)
Phase 4
1 (20.0%)

The Risk Factors of Symptomatic Gallbladder Stone: Age-Sex Matched Case-control Study Performed in Single Institute

Completed
Conditions
Gallstone
First Posted Date
2016-06-21
Last Posted Date
2016-06-21
Lead Sponsor
Cheju Halla General Hospital
Target Recruit Count
342
Registration Number
NCT02808546

Nerve Stimulator Versus Ultrasound-guided Infraclavicular Block

Not Applicable
Completed
Conditions
Pain
First Posted Date
2015-01-26
Last Posted Date
2016-01-28
Lead Sponsor
Cheju Halla General Hospital
Target Recruit Count
44
Registration Number
NCT02344615
Locations
🇰🇷

Cheju Halla General Hopsital, Jeju, Jeju self-governing province, Korea, Republic of

Nerve Stimulator Versus Ultrasound-guided Interscalene Block for Shoulder Surgery

Not Applicable
Completed
Conditions
Pain
First Posted Date
2015-01-21
Last Posted Date
2017-07-17
Lead Sponsor
Cheju Halla General Hospital
Target Recruit Count
53
Registration Number
NCT02342873
Locations
🇰🇷

Cheju Halla General Hopsital, Jeju-si, Jeju special governing province, Korea, Republic of

Alcohol Consumption and Gallbladder Cancer

Completed
Conditions
Gallbladder Cancer
First Posted Date
2014-12-30
Last Posted Date
2014-12-30
Lead Sponsor
Cheju Halla General Hospital
Target Recruit Count
156
Registration Number
NCT02326948
Locations
🇰🇷

Cheju Halla General Hopsital, Jeju-si, Jeju special governing province, Korea, Republic of

Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy

Completed
Conditions
C.Medical Procedure; Digestive System
Disorder of Upper Gastrointestinal Tract
Tolerance
Interventions
Drug: Case Group
First Posted Date
2014-12-04
Last Posted Date
2015-01-13
Lead Sponsor
Cheju Halla General Hospital
Target Recruit Count
497
Registration Number
NCT02307773
Locations
🇰🇷

Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital, Jeju-si, Jeju Special Self-Governing Province, Korea, Republic of

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath